AVA
Atlas Venture Advisors Portfolio holdings
AUM
$424M
This Quarter Return
+63.27%
1 Year Return
+0.16%
3 Year Return
+108.89%
5 Year Return
+64.67%
10 Year Return
–
AUM
$594M
AUM Growth
+$594M
(+52%)
Cap. Flow
-$2.27M
Cap. Flow
% of AUM
-0.38%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$1.21M |
| 2 |
BCYC
Bicycle Therapeutics
BCYC
|
$1.06M |
Sector Composition
| 1 | Consumer Discretionary | 81.99% |
| 2 | Healthcare | 14.12% |
| 3 | Communication Services | 2.91% |
| 4 | Technology | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
DraftKings
DKNG
$23.8B
| $487M | 81.99% | 8,284,008 | – | – |
|
|
TBIO
2
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $52.2M | 8.78% | 3,833,120 -88,888 | -2% | -$1.21M |
|
|
BCYC
3
Bicycle Therapeutics
BCYC
$511M
| $24.9M | 4.19% | 1,306,965 -55,731 | -4% | -$1.06M |
|
4
Roku
ROKU
$14.2B
| $10.9M | 1.83% | 57,707 | – | – |
|
5
Snap
SNAP
$12.1B
| $6.41M | 1.08% | 245,559 | – | – |
|
6
Datadog
DDOG
$47.7B
| $5.78M | 0.97% | 56,616 | – | – |
|
7
Larimar Therapeutics
LRMR
$310M
| $4.43M | 0.75% | 292,184 | – | – |
|
8
Viridian Therapeutics
VRDN
$1.5B
| $2.45M | 0.41% | 3,142,580 | – | – |
|